Novel biomarkers for glycaemic deterioration in type 2 diabetes: an IMI RHAPSODY study
Roderick C Slieker, Louise A Donnelly, Livia Lopez-Noriega, Hermine Muniangi-Muhitu, Elina Akalestou, Mahsa Sheikh, Eleni Georgiadou, Giuseppe N. Giordano, Mikael Åkerlund, Emma Ahlqvist, Ashfaq Ali, Marko Barovic, Gerard A Bouland, Frédéric Burdet, Mickaël Canouil, Iulian Dragan, Petra JM Elders, Celine Fernandez, Andreas Festa, Hugo Fitipaldi, Phillippe Froguel, Valborg Gudmundsdottir, Vilmundur Gudnason, Mathias J. Gerl, Amber A van der Heijden, Lori L Jennings, Michael K. Hansen, Min Kim, Isabelle Leclerc, Christian Klose, Dmitry Kuznetsov, Dina Mansour Aly, Florence Mehl, Diana Marek, Olle Melander, Anne Niknejad, Filip Ottosson, Imre Pavo, Alexander Efanov, Kevin Duffin, Timothy J. Pullen, Kai Simons, Michele Solimena, Tommi Suvitaival, Asger Wretlind, Peter Rossing, Valeriya Lyssenko, Cristina Legido Quigley, Leif Groop, Bernard Thorens, Paul W Franks, Mark Ibberson, Joline WJ Beulens, Leen M ’t Hart, Ewan R Pearson, Guy A Rutter
medRxiv 2021.04.22.21255625; doi: https://doi.org/10.1101/2021.04.22.21255625
